Evidence map›Paper›PMID 39737574›Full record

ArticleFEBS open bio2025

Enhancing human ACE2 expression in mouse models to improve COVID-19 research.

Sun Jiaoyang, Cheng Shaofei, Hong Guangliang, Quan Xiongzhi, Lin Haofeng, Mao Rui, Johannes Grillari, Shi Zheng-Li, Chen Jiekai, Liu Meiqin and 2 more

Abstract read
In one paragraph

Article in FEBS open bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sun JiaoyangCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Cheng ShaofeiCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Hong GuangliangGuangzhou National Laboratory, Guangzhou, China.
Quan XiongzhiCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Lin HaofengWuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Mao RuiLaboratory Animal Research Centre, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Johannes GrillariAustrian Cluster for Tissue Regeneration, Vienna, Austria.
Shi Zheng-LiGuangzhou National Laboratory, Guangzhou, China.
Chen JiekaiCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Liu MeiqinWuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Wu HaoyuCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.ORCID https://orcid.org/0000-0002-8995-3486
Wu GuangmingGuangzhou National Laboratory, Guangzhou, China.

Funding

Basic Research Project of Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences GIBHBRP23-02BMBWF and WTZ-OEAD grant CN 04/2021Health@InnoHK Program launched by Innovation Technology Commission of the Hong Kong SAR, P. R. ChinaMajor Project of Guangzhou National Laboratory GZNL2023A02005Pearl River Talent Recruitment Program 2021ZT09Y233Science and Technology Planning Project of Guangdong Province, China 2023B1212060050Science and Technology Planning Project of Guangdong Province, China 2023B1212120009The Austrian Science Fund (FWF) and 'Herzfelder'sche Familienstiftung project P35268-Bthe National Key R&D Program of China 2021YFE0112900the National Key R&D Program of China 2023YFF1204701The National Natural Science Foundation of China 32225012
6 · The paper itself

Abstract

Mice are one of the most common biological models for laboratory use. However, wild-type mice are not susceptible to COVID-19 infection due to the low affinity of mouse ACE2, the entry protein for SARS-CoV-2. Although mice with human ACE2 (hACE2) driven by Ace2 promoter reflect its tissue specificity, these animals exhibit low ACE2 expression, potentially limiting their fidelity in mimicking COVID-19 manifestations and their utility in viral studies. Here, we created and compared hACE2 mouse models generated with different strategies. Our findings show that distinct β-globin insertion within hACE2 cassette significantly influences its expression, with downstream placement enhancing transcription. Moreover, optimizing hACE2 codons (opt-hACE2) improves translation efficiency in multiple tissues. Notably, opt-hACE2 mice displayed more active immune responses and severe COVID-19 phenotypes following SARS-CoV-2 challenge compared to other models. Our study demonstrates the dual regulatory role of β-globin element in transgene transcription and suggests that opt-hACE2 mice might serve as valuable tools for SARS-CoV-2 research.

Indexed as

Angiotensin-Converting Enzyme 2COVID-19Animalsbeta-GlobinsDisease Models, AnimalHumansMiceMice, TransgenicPromoter Regions, GeneticSARS-CoV-2ACE2 protein, humanAce2 protein, mouseAngiotensin-Converting Enzyme 2beta-GlobinsCOVID‐19hACE2mouse modelβ‐globin

Identifiers

PMID39737574
PMCPMC11788745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.